13-08-2020
Pavel Kapysh / Shutterstock.com
Indian drugmaker Dr Reddy’s has won approval to launch just the second generic version of heart drug Vascepa (icosapent ethyl), in another blow for Amarin.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
FDA, Dr Reddy’s, Vascepa, Amarin, Hikma Pharmaceuticals, patents, generics, Nevada, Miranda Du, cardiovascular
